主页 > 医药生命 >
【Science】不饱和脂肪酸的抗血管增生作用
5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ω-3 Polyunsaturated Fatty Acids
http://stm.sciencemag.org/content/3/69/69ra12.abstract
Lipid signaling is dysregulated in many diseases with vascular pathology, including cancer, diabetic retinopathy, retinopathy of prematurity, and age-related macular degeneration. We have previously demonstrated that diets enriched in ω-3 polyunsaturated fatty acids (PUFAs) effectively reduce pathological retinal neovascularization in a mouse model of oxygen-induced retinopathy, in part through metabolic products that suppress microglial-derived tumor necrosis factor–α. To better understand the protective effects of ω-3 PUFAs, we examined the relative importance of major lipid metabolic pathways and their products in contributing to this effect. ω-3 PUFA diets were fed to four lines of mice deficient in each key lipid-processing enzyme (cyclooxygenase 1 or 2, or lipoxygenase 5 or 12/15), retinopathy was induced by oxygen exposure; only loss of 5-lipoxygenase (5-LOX) abrogated the protection against retinopathy of dietary ω-3 PUFAs. This protective effect was due to 5-LOX oxidation of the ω-3 PUFA lipid docosahexaenoic acid to 4-hydroxy-docosahexaenoic acid (4-HDHA). 4-HDHA directly inhibited endothelial cell proliferation and sprouting angiogenesis via peroxisome proliferator–activated receptor γ (PPARγ), independent of 4-HDHA’s anti-inflammatory effects. Our study suggests that ω-3 PUFAs may be profitably used as an alternative or supplement to current anti–vascular endothelial growth factor (VEGF) treatment for proliferative retinopathy and points to the therapeutic potential of ω-3 PUFAs and metabolites in other diseases of vasoproliferation. It also suggests that cyclooxygenase inhibitors such as aspirin and ibuprofen (but not lipoxygenase inhibitors such as zileuton) might be used without losing the beneficial effect of dietary ω-3 PUFA.
Citation: P. Sapieha, A. Stahl, J. Chen, M. R. Seaward, K. L. Willett, N. M. Krah, R. J. Dennison, K. M. Connor, C. M. Aderman, E. Liclican, A. Carughi, D. Perelman, Y. Kanaoka, J. P. SanGiovanni, K. Gronert, L. E. H. Smith, 5-Lipoxygenase Metabolite 4-HDHA Is a Mediator of the Antiangiogenic Effect of ω-3 Polyunsaturated Fatty Acids. Sci. Transl. Med. 3, 69ra12 (2011). 相关帖子
【科普】一信号通路影响缺血性血管新生
http://news.dxy.cn/bbs/topic/19407494?tpg=1&age=0 染色体 | 生命奥秘不过这种人工合成生命技术也引发了各种科学及社会争议,这次引发的大讨论要比当时对基... 我们早就知道,像存在于鱼油中的EPA这样的多不饱和脂肪酸类物质能够降低我们人体内...www.lifeomics.com/...d=2&s=染色体-2010-07-28-快照-生命奥秘" 2007 年8月13 日第七期文件类型:PDF/Adobe Acrobat- 文字版一些最老的生命形式被发现 多中心研究发现新肺癌抑制基因 《科学》:蛋白折叠研究新突... 前列腺素是存在于动物和人体中的一类 不饱和脂肪酸组成的具有多种生理作用的活 性物...www.ebiotrade.com/...h0813.pdf-2011-01-26-乙烯基吡咯烷酮(NVP)和聚乙烯吡咯烷酮(PVP)生产项目文件类型:DOC/Microsoft Word- 文字版二十二碳六烯酸(DHA) 是一种Omega-3多元不饱和脂肪酸,动物自身难以合成,有重要的生... 寻求境外合作伙伴 联系地址:厦门大学生命科学学院 养生堂北京万泰生物药业有限公司 ...www.xiangankj.gov.cn/...推介.doc-2011-01-20-[标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-02-16 11:57
医学,生命科学网